Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT06668116
Eligibility Criteria:
Inclusion Criteria:
* ASA I - II, both sexes
* ≥ 18 years old
* \< 65 years old
* Written informed consent as documented by signature
Exclusion Criteria:
* Known allergy or hypersensitivity to a ropivacaine, amide local anesthetics or ultrasound gel
* Any history of chronic or acute pain at the moment of enrollment into the study
* Treatment with any substance having a relation to pain or pain modulation (antidepressants, opioids, benzodiazepines, anticonvulsants)
* Intake of any analgesic 48 hours prior to the conduction of any of the study stages
* Severe coagulopathy
* History of cardiovascular disease
* History of alcohol abuse or the intake of psychotropic drugs
* Pregnancy, ruled out by history
* Infection at the injection site or a systemic infection
* Fever of unknown origin
* Motor or sensory abnormalities in the arm
* Previous enrollment into the current study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06668116
Study Brief:
Protocol Section:
NCT06668116